×

Unicorn plans to push diabetes drugs

11:17 AM ET Fri, 1 May 2015

Intarcia Therapeutics Inc. said it raised $225 million in the latest in a series of financing to support the development of its implantable drug-delivery pump for patients with diabetes.Kurt Graves, Intarcia Therapeutics chairman and CEO, discusses.